These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9840728

  • 1. Effect of Cremophor EL on the pharmacokinetics, antitumor activity and toxicity of doxorubicin in mice.
    Badary OA, Al-Shabanah OA, Al-Gharably NM, Elmazar MM.
    Anticancer Drugs; 1998 Oct; 9(9):809-15. PubMed ID: 9840728
    [Abstract] [Full Text] [Related]

  • 2. Differential alteration of cisplatin cytotoxicity and myelotoxicity by the paclitaxel vehicle cremophor EL.
    Badary OA, Abdel-Naim AB, Khalifa AE, Hamada FM.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):339-44. PubMed ID: 10731049
    [Abstract] [Full Text] [Related]

  • 3. Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity.
    al-Shabanah OA, Badary OA, Nagi MN, al-Gharably NM, al-Rikabi AC, al-Bekairi AM.
    J Exp Clin Cancer Res; 1998 Jun; 17(2):193-8. PubMed ID: 9700580
    [Abstract] [Full Text] [Related]

  • 4. Safety, pharmacokinetics and biodistribution studies of a beta-galactoside prodrug of doxorubicin for improvement of tumor selective chemotherapy.
    Devalapally H, Rajan KS, Akkinepally RR, Devarakonda RK.
    Drug Dev Ind Pharm; 2008 Aug; 34(8):789-95. PubMed ID: 18608462
    [Abstract] [Full Text] [Related]

  • 5. Reversal of resistance against doxorubicin by a newly developed compound, oxalyl bis(N-phenyl)hydroxamic acid in vitro.
    Choudhuri SK, Chatterjee A.
    Anticancer Drugs; 1998 Oct; 9(9):825-32. PubMed ID: 9840730
    [Abstract] [Full Text] [Related]

  • 6. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
    Jagetia GC, Reddy TK, Malagi KJ, Nayak BS, Naidu MB, Ravikiran PB, Kamath SU, Shetty PC, Reddy DS.
    Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569
    [Abstract] [Full Text] [Related]

  • 7. Effects of L-histidinol on the antitumour activity and acute cardiotoxicity of doxorubicin in mice.
    Al-Shabanah OA, Badary OA, Al-Gharably NM, Al-Sawaf HA.
    Pharmacol Res; 1998 Sep; 38(3):225-30. PubMed ID: 9782074
    [Abstract] [Full Text] [Related]

  • 8. Boswellic acids synergize antitumor activity and protect against the cardiotoxicity of doxorubicin in mice bearing Ehrlich's carcinoma.
    Ali SA, Zaitone SA, Moustafa YM.
    Can J Physiol Pharmacol; 2015 Aug; 93(8):695-708. PubMed ID: 26230640
    [Abstract] [Full Text] [Related]

  • 9. Enhanced antitumour activity of doxorubicin and simvastatin combination loaded nanoemulsion treatment against a Swiss albino mouse model of Ehrlich ascites carcinoma.
    Alkreathy HM, Alkhatib MH, Al Musaddi SA, Balamash KSA, Osman NN, Ahmad A.
    Clin Exp Pharmacol Physiol; 2019 May; 46(5):496-505. PubMed ID: 30724380
    [Abstract] [Full Text] [Related]

  • 10. Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma.
    El-Ashmawy NE, Khedr EG, Ebeid EM, Salem ML, Zidan AA, Mosalam EM.
    Eur J Pharm Sci; 2017 Nov 15; 109():525-532. PubMed ID: 28890201
    [Abstract] [Full Text] [Related]

  • 11. Effect of dihydrokainate on the antitumor activity of doxorubicin.
    Sadzuka Y, Yamashita Y, Sugiyama T, Sonobe T.
    Cancer Lett; 2002 May 28; 179(2):157-63. PubMed ID: 11888670
    [Abstract] [Full Text] [Related]

  • 12. Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Ganguly A, Chakraborty P, Banerjee K, Chatterjee S, Basu S, Sarkar A, Chatterjee M, Choudhuri SK.
    Biometals; 2012 Feb 28; 25(1):149-63. PubMed ID: 21915630
    [Abstract] [Full Text] [Related]

  • 13. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Majumder S, Dutta P, Mookerjee A, Choudhuri SK.
    Chem Biol Interact; 2006 Feb 01; 159(2):90-103. PubMed ID: 16289015
    [Abstract] [Full Text] [Related]

  • 14. The antitumor effects of tetrodotoxin and/or doxorubicin on Ehrlich ascites carcinoma-bearing female mice.
    El-Dayem SM, Fouda FM, Ali EH, Motelp BA.
    Toxicol Ind Health; 2013 Jun 01; 29(5):404-17. PubMed ID: 22317827
    [Abstract] [Full Text] [Related]

  • 15. Synergistic effect of probimane on anticancer cytotoxicity of doxorubicin in vitro.
    Zhang Y, Ye QX, Liu J, Zhang ZY, Zhang TM.
    Zhongguo Yao Li Xue Bao; 1994 Jan 01; 15(1):56-9. PubMed ID: 8010087
    [Abstract] [Full Text] [Related]

  • 16. Modulatory effects of melatonin and vitamin E on doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma-bearing mice.
    Wahab MH, Akoul ES, Abdel-Aziz AA.
    Tumori; 2000 Jan 01; 86(2):157-62. PubMed ID: 10855855
    [Abstract] [Full Text] [Related]

  • 17. A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo.
    Mookerjee A, Basu JM, Majumder S, Chatterjee S, Panda GS, Dutta P, Pal S, Mukherjee P, Efferth T, Roy S, Choudhuri SK.
    BMC Cancer; 2006 Nov 15; 6():267. PubMed ID: 17107616
    [Abstract] [Full Text] [Related]

  • 18. CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity.
    Dubois V, Dasnois L, Lebtahi K, Collot F, Heylen N, Havaux N, Fernandez AM, Lobl TJ, Oliyai C, Nieder M, Shochat D, Yarranton GT, Trouet A.
    Cancer Res; 2002 Apr 15; 62(8):2327-31. PubMed ID: 11956091
    [Abstract] [Full Text] [Related]

  • 19. The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor.
    Friche E, Jensen PB, Sehested M, Demant EJ, Nissen NN.
    Cancer Commun; 1990 Apr 15; 2(9):297-303. PubMed ID: 1976341
    [Abstract] [Full Text] [Related]

  • 20. Dioscorea bulbifera L. delays the excretion of doxorubicin and aggravates doxorubicin-induced cardiotoxicity and nephrotoxicity by inhibiting the expression of P-glycoprotein in mice liver and kidney.
    Qu X, Zhai J, Hu T, Gao H, Tao L, Zhang Y, Song Y, Zhang S.
    Xenobiotica; 2019 Sep 15; 49(9):1116-1125. PubMed ID: 29985077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.